It is the best of times; It is the worst of times: Is there a way forward? A plethora of treatment options for rheumatoid arthritis, but critical trial design issues

被引：8

作者：

O'Dell, James R. ^{[1
]}

机构：

[1] Univ Nebraska, Med Ctr, Omaha, NE 68198 USA

来源：

ARTHRITIS AND RHEUMATISM | 2007年 / 56卷 / 12期

关键词：

D O I：

10.1002/art.23140

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3884 / 3886

页数：3

共 15 条

[1] Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate - Results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial [J].

Cohen, S ;

Hurd, E ;

Cush, J ;

Schiff, M ;

Weinblatt, ME ;

Moreland, LW ;

Kremer, J ;

Bear, MB ;

Rich, WJ ;

McCabe, D .

ARTHRITIS AND RHEUMATISM, 2002, 46 (03) :614-624

[2] Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].

Edwards, JCW ;

Szczepanski, L ;

Szechinski, J ;

Filipowicz-Sosnowska, A ;

Emery, P ;

Close, DR ;

Stevens, RM ;

Shaw, T .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581

[3] Comparison of treatment strategies in early rheumatoid arthritis - A randomized trial [J].

Goekoop-Ruiterman, Yvonne P. M. ;

de Vries-Bouwstra, Jeska K. ;

Allaart, Cornelia F. ;

van Zeben, Derkjen ;

Kerstens, Pit J. S. M. ;

Hazes, J. Mieke W. ;

Zwinderman, Aelko H. ;

Peeters, Andre J. ;

de Jonge-Bok, Johanna M. ;

Mallee, Constant ;

de Beus, Wim M. ;

de Sonnaville, Peter B. J. ;

Ewals, Jacques A. P. M. ;

Breedveld, Ferdinand C. ;

Dijkmans, Ben A. C. .

ANNALS OF INTERNAL MEDICINE, 2007, 146 (06) :406-415

[4] Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial [J].

Grigor, C ;

Capell, H ;

Stirling, A ;

McMahon, AD ;

Lock, P ;

Vallance, R ;

Kincaid, W ;

Porter, D .

LANCET, 2004, 364 (9430) :263-269

[5] Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy - A randomized, placebo-controlled, 52-week trial [J].

Keystone, EC ;

Kavanaugh, AF ;

Sharp, JT ;

Tannenbaum, H ;

Hua, Y ;

Teoh, LS ;

Fischkoff, SA ;

Chartash, EK .

ARTHRITIS AND RHEUMATISM, 2004, 50 (05) :1400-1411

[6]

Kremer JM, 2000, ARTHRITIS RHEUM, V43, pS224

[7] Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis - A randomized trial [J].

Kremer, Joel M. ;

Genant, Harry K. ;

Moreland, Larry W. ;

Russell, Anthony S. ;

Emery, Paul ;

Abud-Mendoza, Carlos ;

Szechinski, Jacek ;

Li, Tracy ;

Ge, Zhiyu ;

Becker, Jean-Claude ;

Westhovens, Rene .

ANNALS OF INTERNAL MEDICINE, 2006, 144 (12) :865-876

[8]

Kwoh CK, 2002, ARTHRITIS RHEUM-US, V46, P328

[9] A 48-week, randomized, double-blind, double-observer, placebo- controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis - Results of The METGO Study [J].

Lehman, AJ ;

Esdaile, JM ;

Klinkhoff, AV ;

Grant, E ;

Fitzgerald, A ;

Canvin, J .

ARTHRITIS AND RHEUMATISM, 2005, 52 (05) :1360-1370

[10] Infliximab and methotrexate in the treatment of rheumatoid arthritis [J].

Lipsky, PE ;

van der Heijde, DMFM ;

St Clair, EW ;

Furst, DE ;

Breedveld, FC ;

Kalden, JR ;

Smolen, JS ;

Weisman, M ;

Emery, P ;

Feldmann, M ;

Harriman, GR ;

Maini, RN .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1594-1602

← 1 2 →